U.S. Sleep Supplement Preferences Shift Toward Botanicals

Adults are increasingly choosing magnesium and herbal aids over melatonin to support their nightly recovery.

Updated on Oct. 27, 2026 in Sleep Disorders

Bold vector editorial illustration showing an amber supplement jar next to botanical ingredients, representing the shift in sleep supplement preferences. — U.S. consumers are increasingly shifting toward botanical and magnesium-based supplements to manage sleep quality and stress, moving away from melatonin. AI Illustration. Upload story photo >

Live Poll

Is now a good time to switch from melatonin to alternative sleep supplements for better rest?

Data from the 52 weeks ending Oct. 4, 2026, shows a shift in U.S. sleep aid trends as consumers move away from melatonin toward magnesium and botanicals. This shift reflects a growing emphasis on stress management and sleep quality.

Why it matters

The market is evolving because Americans are increasingly prioritizing overall recovery and stress reduction rather than focusing solely on falling asleep. With 30.5% of U.S. adults reporting less than seven hours of sleep in 2024, this change highlights a transition in how individuals manage rest.

Total sleep supplement sales reached $1.01 billion over the 52 weeks ending Oct. 4, 2026, reflecting a 1.1% growth rate. While melatonin remains the market leader, magnesium sales rose 22.8% to $91.5 million and reishi mushroom sales grew 53.7%.

The details

Consumers are increasingly adopting new delivery formats such as liquid ready-to-drink products, soft chews, and patches to integrate relaxation support into their daily routines. Formulations are expanding beyond traditional sleep aids to include ingredients like glycine and saffron, which are marketed to target stress management and overall sleep quality rather than acting strictly as sedatives.

2024 saw 30.5% of U.S. adults report sleeping less than seven hours per night.
The consumer survey was fielded on August 11, 2026.
Sales data covers the 52-week period ending Oct. 4, 2026.

Health Landscape

This shift follows the trajectory identified in recent SPINS market analysis regarding dietary supplement consumer preferences. It marks a departure from a heavy reliance on melatonin, suggesting a broader medical trend toward multimodal stress and recovery management.

If you are exploring new sleep support options, it is worth discussing with your doctor how these non-melatonin ingredients might interact with your specific health goals. Be aware that many of these products are marketed for general relaxation rather than as clinical treatments for chronic insomnia.

The takeaway

The move toward magnesium and botanical supplements highlights a shift toward supporting the body's natural stress response rather than just chasing sedation. When choosing any sleep-focused product, consult your physician to ensure it aligns with your overall care plan and existing medications.